David A. Siegel Lantern Pharma Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding LTRN
# of Institutions
38Shares Held
1.07MCall Options Held
124KPut Options Held
22.2K-
Vanguard Group Inc Valley Forge, PA364KShares$1.7 Million0.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA161KShares$749,6840.01% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$408,0360.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny65.7KShares$306,8190.0% of portfolio
-
Cm Management, LLC65KShares$303,5500.5% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $50.6M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...